Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    2215615 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study Of Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability)
Condition: Hyperlipidemia
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Second Formulation;   Dietary Supplement: Third Formulation
2 Terminated Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis
Condition: Atherosclerosis
Interventions: Drug: extended release niacin;   Drug: ezetimibe
3 Completed Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment
Conditions: Coronary Disease;   Ultrasonography, Interventional;   Hydroxymethylglutaryl-CoA Reductase Inhibitors
Intervention: Drug: Atorvastatin 10mg versus 40mg.
4 Completed Familial Atherosclerosis Treatment Study
Conditions: Cardiovascular Diseases;   Coronary Arteriosclerosis;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia
Interventions: Drug: lovastatin;   Drug: colestipol;   Drug: niacin

Indicates status has not been verified in more than two years